The American wholesaler AmerisourceBergen Corporation has today completed a deal to acquire Alliance Healthcare.

AmerisourceBergen said the deal was finalised for $6.275 billion in cash “subject to a customary working capital and net debt adjustment” as well as two million shares of the company’s common stock.

AmerisourceBergen chairman, president and chief executive officer Steven H. Collis said the acquisition of Alliance Healthcare will allow his company to expand its “reach and solutions in pharmaceutical distribution and adds to AmerisourceBergen’s breadth and depth of global manufacturer services.”

“With Alliance Healthcare, we will advance our ability to provide innovative and global healthcare solutions and further our purpose of being united in our responsibility to create healthier futures,” he said.

Alliance Healthcare UK managing director Julian Mount said: “The opportunity to join AmerisourceBergen is a positive step forward for Alliance Healthcare and affords us the chance to expand, evolve and innovate on each other’s best-in-class expertise and capabilities across the pharmaceutical supply chain.

“Our combined experience from pre-commercial and clinical trial, to broad market availability and patient adherence, will allow us to build new services and solutions that further support healthcare advancements around the world and enable us to better support our NHS and ultimately the patients they serve.”